These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 28454808)

  • 1. An examination of the relationship between serum uric acid level, a clinical history of gout, and cardiovascular outcomes among patients with acute coronary syndrome.
    Pagidipati NJ; Hess CN; Clare RM; Akerblom A; Tricoci P; Wojdyla D; Keenan RT; James S; Held C; Mahaffey KW; Klein AB; Wallentin L; Roe MT
    Am Heart J; 2017 May; 187():53-61. PubMed ID: 28454808
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Failure to reach uric acid target of <0.36 mmol/L in hyperuricaemia of gout is associated with elevated total and cardiovascular mortality.
    Pérez Ruiz F; Richette P; Stack AG; Karra Gurunath R; García de Yébenes MJ; Carmona L
    RMD Open; 2019; 5(2):e001015. PubMed ID: 31673414
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An evaluation of longitudinal changes in serum uric acid levels and associated risk of cardio-metabolic events and renal function decline in gout.
    Desai RJ; Franklin JM; Spoendlin-Allen J; Solomon DH; Danaei G; Kim SC
    PLoS One; 2018; 13(2):e0193622. PubMed ID: 29489919
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of the Relationship Between Serum Uric Acid Levels and Cardiovascular Events in Patients With Gout: A Retrospective Analysis Using Electronic Medical Record Data.
    Essex MN; Hopps M; Bienen EJ; Udall M; Mardekian J; Makinson GT
    J Clin Rheumatol; 2017 Apr; 23(3):160-166. PubMed ID: 28248798
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum uric acid, gout, and venous thromboembolism: The atherosclerosis risk in communities study.
    Kubota Y; McAdams-DeMarco M; Folsom AR
    Thromb Res; 2016 Aug; 144():144-8. PubMed ID: 27337701
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Uric acid fluctuation had no effect on renal function among gout patients.
    Shen J; Zhu J; Si S; Fu Y; Mo M; Xin X; Shao B; Shen Y; Wang S; Wu H; Yu Y
    Nutr Metab Cardiovasc Dis; 2020 Sep; 30(10):1833-1839. PubMed ID: 32675011
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of Accumulated Serum Uric Acid on Coronary Culprit Lesion Morphology Determined by Optical Coherence Tomography and Cardiac Outcomes in Patients with Acute Coronary Syndrome.
    Kobayashi N; Asai K; Tsurumi M; Shibata Y; Okazaki H; Shirakabe A; Goda H; Uchiyama S; Tani K; Takano M; Shimizu W
    Cardiology; 2018; 141(4):190-198. PubMed ID: 30759435
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relation of Elevated Serum Uric Acid Level to Endothelial Dysfunction in Patients with Acute Coronary Syndrome.
    Saito Y; Kitahara H; Nakayama T; Fujimoto Y; Kobayashi Y
    J Atheroscler Thromb; 2019 Apr; 26(4):362-367. PubMed ID: 30210087
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hyperuricemia and untreated gout are poor prognostic markers among those with a recent acute myocardial infarction.
    Krishnan E; Pandya BJ; Lingala B; Hariri A; Dabbous O
    Arthritis Res Ther; 2012 Jan; 14(1):R10. PubMed ID: 22251426
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Uric acid and sodium-glucose cotransporter-2 inhibition with empagliflozin in heart failure with reduced ejection fraction: the EMPEROR-reduced trial.
    Doehner W; Anker SD; Butler J; Zannad F; Filippatos G; Ferreira JP; Salsali A; Kaempfer C; Brueckmann M; Pocock SJ; Januzzi JL; Packer M
    Eur Heart J; 2022 Sep; 43(36):3435-3446. PubMed ID: 35788657
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relation of Coronary Culprit Lesion Morphology Determined by Optical Coherence Tomography and Cardiac Outcomes to Serum Uric Acid Levels in Patients With Acute Coronary Syndrome.
    Kobayashi N; Hata N; Tsurumi M; Shibata Y; Okazaki H; Shirakabe A; Takano M; Seino Y; Shimizu W
    Am J Cardiol; 2018 Jul; 122(1):17-25. PubMed ID: 29678337
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Achievement of Target Serum Uric Acid Levels and Factors Associated with Therapeutic Failure among Japanese Men Treated for Hyperuricemia/Gout.
    Katayama A; Yokokawa H; Fukuda H; Ono Y; Isonuma H; Hisaoka T; Naito T
    Intern Med; 2019 May; 58(9):1225-1231. PubMed ID: 30626825
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of noncompliance with urate-lowering drug on serum urate and gout-related healthcare costs: administrative claims analysis.
    Halpern R; Mody RR; Fuldeore MJ; Patel PA; Mikuls TR
    Curr Med Res Opin; 2009 Jul; 25(7):1711-9. PubMed ID: 19485724
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum uric acid levels and the risk of flares among gout patients in a US managed care setting.
    Shiozawa A; Buysman EK; Korrer S
    Curr Med Res Opin; 2017 Jan; 33(1):117-124. PubMed ID: 27659103
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potency on lowering serum uric acid in gout patients: a pooled analysis of registrative studies comparing febuxostat vs. allopurinol.
    Cutolo M; Cimmino MA; Perez-Ruiz F
    Eur Rev Med Pharmacol Sci; 2017 Sep; 21(18):4186-4195. PubMed ID: 29028079
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum uric acid levels during dual antiplatelet therapy with ticagrelor or clopidogrel: Results from a single-centre study.
    Nardin M; Verdoia M; Pergolini P; Rolla R; Barbieri L; Schaffer A; Marino P; Bellomo G; Suryapranata H; De Luca G;
    Nutr Metab Cardiovasc Dis; 2016 Jul; 26(7):567-574. PubMed ID: 27134063
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Crystal-proven gout patients have an increased mortality due to cardiovascular diseases, cancer, and infectious diseases especially when having tophi and/or high serum uric acid levels: a prospective cohort study.
    Disveld IJM; Zoakman S; Jansen TLTA; Rongen GA; Kienhorst LBE; Janssens HJEM; Fransen J; Janssen M
    Clin Rheumatol; 2019 May; 38(5):1385-1391. PubMed ID: 30929152
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patients with gout differ from healthy subjects in renal response to changes in serum uric acid.
    Liu S; Perez-Ruiz F; Miner JN
    Joint Bone Spine; 2017 Mar; 84(2):183-188. PubMed ID: 27324603
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The impact of serum uric acid on cardiovascular outcomes in the LIFE study.
    Høieggen A; Alderman MH; Kjeldsen SE; Julius S; Devereux RB; De Faire U; Fyhrquist F; Ibsen H; Kristianson K; Lederballe-Pedersen O; Lindholm LH; Nieminen MS; Omvik P; Oparil S; Wedel H; Chen C; Dahlöf B;
    Kidney Int; 2004 Mar; 65(3):1041-9. PubMed ID: 14871425
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum uric acid is associated with mortality and heart failure hospitalizations in patients with complicated myocardial infarction: findings from the High-Risk Myocardial Infarction Database Initiative.
    von Lueder TG; Girerd N; Atar D; Agewall S; Lamiral Z; Kanbay M; Pitt B; Dickstein K; Zannad F; Rossignol P;
    Eur J Heart Fail; 2015 Nov; 17(11):1144-51. PubMed ID: 26424212
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.